HLB Co., Ltd. (028300.KQ)
KRW 54100.0
(2.46%)
KRW 54100.0
(2.46%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 751.72 Billion KRW | -22.28% |
| 2022 | 967.26 Billion KRW | 30.06% |
| 2021 | 743.69 Billion KRW | 5.27% |
| 2020 | 706.47 Billion KRW | 94.83% |
| 2019 | 362.61 Billion KRW | 19.26% |
| 2018 | 304.04 Billion KRW | 61.56% |
| 2017 | 188.19 Billion KRW | 0.8% |
| 2016 | 186.7 Billion KRW | 0.83% |
| 2015 | 185.17 Billion KRW | 241.32% |
| 2014 | 54.25 Billion KRW | 50.27% |
| 2013 | 36.1 Billion KRW | -27.77% |
| 2012 | 49.98 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 861.55 Billion KRW | 14.61% |
| 2024 Q2 | 778.9 Billion KRW | -9.59% |
| 2023 Q3 | 871.79 Billion KRW | -4.96% |
| 2023 Q2 | 917.28 Billion KRW | -4.43% |
| 2023 FY | 751.72 Billion KRW | -22.28% |
| 2023 Q1 | 959.83 Billion KRW | -0.77% |
| 2023 Q4 | 751.72 Billion KRW | -13.77% |
| 2022 Q4 | 967.26 Billion KRW | 18.19% |
| 2022 Q3 | 818.42 Billion KRW | 0.65% |
| 2022 Q2 | 813.14 Billion KRW | 6.9% |
| 2022 Q1 | 760.62 Billion KRW | 2.28% |
| 2022 FY | 967.26 Billion KRW | 30.06% |
| 2021 Q4 | 743.69 Billion KRW | 7.02% |
| 2021 Q2 | 668.72 Billion KRW | -4.33% |
| 2021 FY | 743.69 Billion KRW | 5.27% |
| 2021 Q1 | 699.01 Billion KRW | -1.06% |
| 2021 Q3 | 694.87 Billion KRW | 3.91% |
| 2020 Q1 | 356.77 Billion KRW | -1.61% |
| 2020 FY | 706.47 Billion KRW | 94.83% |
| 2020 Q2 | 694 Billion KRW | 94.52% |
| 2020 Q3 | 657.39 Billion KRW | -5.27% |
| 2020 Q4 | 706.47 Billion KRW | 7.47% |
| 2019 Q1 | 319.21 Billion KRW | 4.99% |
| 2019 Q2 | 297.41 Billion KRW | -6.83% |
| 2019 FY | 362.61 Billion KRW | 19.26% |
| 2019 Q4 | 362.61 Billion KRW | 9.83% |
| 2019 Q3 | 330.15 Billion KRW | 11.01% |
| 2018 Q1 | 231.67 Billion KRW | 23.11% |
| 2018 Q4 | 304.04 Billion KRW | 13.69% |
| 2018 Q3 | 267.42 Billion KRW | -4.27% |
| 2018 Q2 | 279.34 Billion KRW | 20.58% |
| 2018 FY | 304.04 Billion KRW | 61.56% |
| 2017 Q4 | 188.19 Billion KRW | -6.56% |
| 2017 FY | 188.19 Billion KRW | 0.8% |
| 2017 Q1 | 183.18 Billion KRW | -1.88% |
| 2017 Q2 | 179.98 Billion KRW | -1.75% |
| 2017 Q3 | 201.41 Billion KRW | 11.9% |
| 2016 Q3 | 194.05 Billion KRW | 3.3% |
| 2016 FY | 186.7 Billion KRW | 0.83% |
| 2016 Q4 | 186.7 Billion KRW | -3.79% |
| 2016 Q2 | 187.84 Billion KRW | -1.38% |
| 2016 Q1 | 190.47 Billion KRW | 2.86% |
| 2015 Q1 | 94.36 Billion KRW | 73.95% |
| 2015 Q4 | 185.17 Billion KRW | 99.67% |
| 2015 FY | 185.17 Billion KRW | 241.32% |
| 2015 Q2 | 94.27 Billion KRW | -0.1% |
| 2015 Q3 | 92.73 Billion KRW | -1.63% |
| 2014 Q4 | 54.25 Billion KRW | 23.23% |
| 2014 Q3 | 44.02 Billion KRW | 5.19% |
| 2014 Q2 | 41.85 Billion KRW | -2.67% |
| 2014 Q1 | 42.99 Billion KRW | 19.1% |
| 2014 FY | 54.25 Billion KRW | 50.27% |
| 2013 Q4 | 36.1 Billion KRW | -13.96% |
| 2013 FY | 36.1 Billion KRW | -27.77% |
| 2013 Q1 | 53.39 Billion KRW | 6.83% |
| 2013 Q3 | 41.95 Billion KRW | -11.74% |
| 2013 Q2 | 47.53 Billion KRW | -10.97% |
| 2012 Q4 | 49.98 Billion KRW | 0.0% |
| 2012 FY | 49.98 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| iNtRON Biotechnology, Inc. | 98.61 Billion KRW | -662.282% |
| BINEX Co., Ltd. | 257.01 Billion KRW | -192.486% |
| Bioneer Corporation | 315.48 Billion KRW | -138.273% |
| Anterogen.Co.,Ltd. | 149.43 Billion KRW | -403.054% |
| MEDIPOST Co., Ltd. | 449.39 Billion KRW | -67.275% |
| CrystalGenomics, Inc. | 243.11 Billion USD | -209.203% |
| Helixmith Co., Ltd | 227.27 Billion KRW | -230.748% |
| Chabiotech Co.,Ltd. | 1725.57 Billion KRW | 56.436% |
| Medy-Tox Inc. | 611.62 Billion KRW | -22.906% |
| Peptron, Inc. | 52.49 Billion KRW | -1331.961% |
| Amicogen, Inc. | 467.09 Billion KRW | -60.934% |
| Genexine, Inc. | 376.58 Billion KRW | -99.615% |
| HLB Therapeutics Co.,Ltd. | 200.79 Billion KRW | -274.373% |
| LegoChem Biosciences, Inc. | 189.5 Billion KRW | -296.682% |
| ALTEOGEN Inc. | 256.09 Billion KRW | -193.527% |
| PharmaResearch Co., Ltd. | 535.28 Billion KRW | -40.435% |
| SillaJen, Inc. | 76.71 Billion KRW | -879.89% |
| JETEMA, Co., Ltd. | 252.14 Billion KRW | -198.128% |
| OliX Pharmaceuticals,Inc | 102.82 Billion KRW | -631.069% |
| Genomictree Inc. | 132.84 Billion KRW | -465.868% |
| MedPacto, Inc. | 80.47 Billion KRW | -834.113% |
| D&D Pharmatech | 79.2 Billion KRW | -849.1% |
| EASY BIO,Inc. | 172.04 Billion KRW | -336.942% |
| GI Innovation, Inc. | 81.34 Billion KRW | -824.17% |